CDK-IN-16
CDK-IN-16 (Compound 5g) is a CDK2/cyclin A2 inhibitor with an IC50 of 1.67 μM. CDK-IN-16 exhibits anticancer activity. The IC50 of CDK-IN-16 against the AGS cell line is 3.5 μM[1].
Product Specifications
UNSPSC
12352005
Target
CDK
Related Pathways
Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
OC1=CC=C(C2=C3CCC4=CC=CC=C4C3=NC(C5=CC=CN=C5)=N2)C=C1
Molecular Formula
C23H17N3O
Molecular Weight
351.40
References & Citations
[1]Saravanakumar N, et al. Novel Fused Pyrimidines as Potent Cyclin-Dependent Kinases Inhibitor for Gastric Adenocarcinoma: Combined In Vitro, In Silico Anticancer Studies. Chem Biol Drug Des. 2024 Nov;104 (5) :e70013.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR10476161 96 Well
Canine Receptor II for the Fc region of immunoglobulin E ELISA kit
Sign In for Pricing
View Details 
126617-ML650 100 µL
FANCF (Fanconi Anemia Group B Protein, Protein FACB, Fanconi Anemia-associated Polypeptide of 95kD, FAAP95, MGC126856) (MaxLight 650)
Sign In for Pricing
View Details 
orb2844991 100 µL
Phospho-Paxillin (Tyr88) Rabbit pAb, PerCP-Cy7 conjugated
Sign In for Pricing
View Details